Skip to main content

Advertisement

SpringerLink
Log in

Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction

Physician-patient misalignment may exist in real-life clinical practice. We aimed to assess physician and patient treatment satisfaction levels and associated degree of misalignment in psoriatic arthritis (PsA).

Method

Data from a cross-sectional survey of patients and their physicians conducted in Latin America were analyzed. Physician-reported and patient-reported satisfaction levels with current PsA treatment, alignment in satisfaction levels, and factors associated with satisfaction misalignment were assessed through bivariable and multivariable regression analyses.

Results

A total of 179 physician-patient pairs were analyzed. Physicians reported satisfaction with current disease control in 87.7% (n = 157) of cases; patients reported satisfaction in 91.1% (n = 163 of cases). A total of 82.1% of physician-patient pairs were aligned. Compared with aligned patients, misaligned patients were older and more likely to have moderate or severe disease, deteriorating or unstable disease, a past hospital procedure, current or past psoriasis symptoms, greater current pain, a current acute episode, poorer health and quality of life, greater impairment, poorer medication compliance, to consider PsA a major daily burden, and to believe that PsA treatments were ineffective. Misaligned patients were less likely to be in remission. Logistic regression analysis revealed that misaligned patients were older, and more likely to consider PsA a major daily burden and PsA treatments as ineffective.

Conclusions

High levels of treatment satisfaction and alignment were observed among PsA patients and their physicians in Latin America. Patients in this study nevertheless experienced a considerable clinical and quality-of-life burden, especially the misaligned patients. Addressing misalignment may lead to improved PsA disease control.

Key points

• High treatment satisfaction was observed among PsA patients and their treating physicians in Latin America.

• Patients experienced a considerable clinical and quality-of-life burden, especially the misaligned patients.

• One-fifth of physician-patient pairs were misaligned regarding satisfaction.

• Understanding and addressing misalignment may improve outcomes in this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391(10136):2273–2284. https://doi.org/10.1016/S0140-6736(18)30830-4

    Article  CAS  PubMed  Google Scholar 

  2. Van den Bosch F, Coates L (2018) Clinical management of psoriatic arthritis. Lancet 391(10136):2285–2294. https://doi.org/10.1016/S0140-6736(18)30949-8

    Article  PubMed  Google Scholar 

  3. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A (2018) Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2018.06.027

    Article  Google Scholar 

  4. Maldonado Ficco H, Citera G, Maldonado Cocco JA (2014) Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. Clin Rheumatol 33(2):243–246. https://doi.org/10.1007/s10067-013-2412-2

    Article  PubMed  Google Scholar 

  5. Ranza R, Carneiro S, Qureshi AA, Martins G, Rodrigues JJ, Romiti R, Barros TB, Carneiro J, Sampaio AL, Grynszpan R, Markus J, Pinto RM, Goldenstein-Schainberg C (2015) Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis. J Rheumatol 42(5):829–834. https://doi.org/10.3899/jrheum.140474

    Article  PubMed  Google Scholar 

  6. Soriano ER, Rosa J, Velozo E, Schpilberg M, Imamura PM, Diaz J, Catoggio LJ (2011) Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) 50(4):729–734. https://doi.org/10.1093/rheumatology/keq369

    Article  Google Scholar 

  7. Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin N Am 41(4):545–568. https://doi.org/10.1016/j.rdc.2015.07.001

    Article  Google Scholar 

  8. Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewe R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Canete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499–510. https://doi.org/10.1136/annrheumdis-2015-208337

    Article  CAS  PubMed  Google Scholar 

  9. Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O’Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheum 68(5):1060–1071. https://doi.org/10.1002/art.39573

    Article  Google Scholar 

  10. Elmamoun M, Eraso M, Maharaj A, Chandran V, Coates L, Adebajo A, Sharma A, Toloza S, Vega-E L, Vega-H O, Abogamal A, Ajibade A, Ayanlowo O, Azevedo V, Bautista-M W, Carneiro S, Goldenstein-S C, Hernandez-V F, Ima-E U, Lima A, Medina-R J, Mody G, Narang T, Ortega-L A, Ranza R (2018) OP0312 International League Of Associations for Rheumatology (ILAR) treatment recommendations for psoriatic arthritis in resource-poor countries. Ann Rheum Dis 77(Suppl 2):203–203. https://doi.org/10.1136/annrheumdis-2018-eular.5536

    Article  Google Scholar 

  11. Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J (2019) Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheum 71(1):5–32. https://doi.org/10.1002/art.40726

    Article  Google Scholar 

  12. Felquer ML, Soriano ER (2015) New treatment paradigms in psoriatic arthritis: an update on new therapeutics approved by the U.S. Food and Drug Administration. Curr Opin Rheumatol 27(2):99–106. https://doi.org/10.1097/BOR.0000000000000151

    Article  CAS  PubMed  Google Scholar 

  13. Shikiar R, Rentz AM (2004) Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 7(2):204–215. https://doi.org/10.1111/j.1524-4733.2004.72252.x

    Article  PubMed  Google Scholar 

  14. Delestras S, Roustit M, Bedouch P, Minoves M, Dobremez V, Mazet R, Lehmann A, Baudrant M, Allenet B (2013) Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases. PLoS One 8(2):e56247. https://doi.org/10.1371/journal.pone.0056247

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR (2004) Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2:12. https://doi.org/10.1186/1477-7525-2-12

    Article  PubMed  PubMed Central  Google Scholar 

  16. Atkinson MJ, Kumar R, Cappelleri JC, Hass SL (2005) Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 8(Suppl 1):S9–S24. https://doi.org/10.1111/j.1524-4733.2005.00066.x

    Article  PubMed  Google Scholar 

  17. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M (1997) Issues in the measurement of satisfaction with treatment. Am J Manag Care 3(4):579–594

    CAS  PubMed  Google Scholar 

  18. Mercy KM, Gordon KB, Paller AS (2014) Patient satisfaction and quality of life in psoriasis and psoriatic arthritis. JAMA 312(24):2676–2677. https://doi.org/10.1001/jama.2014.12494

    Article  CAS  PubMed  Google Scholar 

  19. Finlay AY, Ortonne JP (2004) Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy. J Cutan Med Surg 8(5):310–320. https://doi.org/10.1177/120347540400800502

    Article  PubMed  Google Scholar 

  20. Duffin KC, Yeung H, Takeshita J, Krueger GG, Robertson AD, Troxel AB, Shin DB, Van Voorhees AS, Gelfand JM (2014) Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol 170(3):672–680. https://doi.org/10.1111/bjd.12745

    Article  PubMed  PubMed Central  Google Scholar 

  21. Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG (2013) Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol 149(10):1180–1185. https://doi.org/10.1001/jamadermatol.2013.5264

    Article  CAS  PubMed  Google Scholar 

  22. Selzer RM, Ellen S, McGartland M (2013) Alignment: a conceptual shift from adherence. Intern Med J 43(8):940–942. https://doi.org/10.1111/imj.12212

    Article  CAS  PubMed  Google Scholar 

  23. Fuertes JN, Anand P, Haggerty G, Kestenbaum M, Rosenblum GC (2015) The physician-patient working alliance and patient psychological attachment, adherence, outcome expectations, and satisfaction in a sample of rheumatology patients. Behav Med 41(2):60–68. https://doi.org/10.1080/08964289.2013.875885

    Article  PubMed  Google Scholar 

  24. Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E, Kemhus M (2016) Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Dermatol Online J 22(7)

  25. Furst DE, Tran M, Sullivan E, Pike J, Piercy J, Herrera V, Palmer JB (2017) Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control. Clin Rheumatol 36(9):2045–2054. https://doi.org/10.1007/s10067-017-3578-9

    Article  PubMed  PubMed Central  Google Scholar 

  26. Anderson P, Benford M, Harris N, Karavali M, Piercy J (2008) Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand. Curr Med Res Opin 24(11):3063–3072. https://doi.org/10.1185/03007990802457040

    Article  CAS  PubMed  Google Scholar 

  27. Babineaux SM, Curtis B, Holbrook T, Milligan G, Piercy J (2016) Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the disease specific programme. BMJ Open 6(8):e010352. https://doi.org/10.1136/bmjopen-2015-010352

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M (2016) Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes 9:371–380. https://doi.org/10.2147/DMSO.S120101

    Article  PubMed  PubMed Central  Google Scholar 

  29. van Reenen MOM (2015) EQ-5D-3L User Guide. EuroQol Research Foundation, Rotterdam

    Google Scholar 

  30. Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD (2011) The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res 63(Suppl 11):S486–S490. https://doi.org/10.1002/acr.20581

    Article  Google Scholar 

  31. Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5):353–365. https://doi.org/10.2165/00019053-199304050-00006

    Article  CAS  PubMed  Google Scholar 

  32. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

    Article  CAS  Google Scholar 

  33. Aletaha D, Alasti F, Smolen JS (2016) Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point. Ann Rheum Dis 75(8):1479–1485. https://doi.org/10.1136/annrheumdis-2015-208324

    Article  PubMed  Google Scholar 

  34. Services UDoHaH (2003) Summary of the HIPAA Privacy Rule. http://www.hhs.gov/sites/default/files/privacysummary.pdf. Accessed 25 August 2018

  35. Technology HI Health Information Technology Act. https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/administrative/enforcementrule/enfifr.pdf?language=es. Accessed 25 August 2018

  36. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174

    Article  CAS  Google Scholar 

  37. Dandorfer SW, Rech J, Manger B, Schett G, Englbrecht M (2012) Differences in the patient’s and the physician’s perspective of disease in psoriatic arthritis. Semin Arthritis Rheum 42(1):32–41. https://doi.org/10.1016/j.semarthrit.2011.12.003

    Article  PubMed  Google Scholar 

  38. Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD (2015) Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res 67(2):264–272. https://doi.org/10.1002/acr.22401

    Article  Google Scholar 

  39. Kostova Z, Caiata-Zufferey M, Schulz PJ (2014) The process of acceptance among rheumatoid arthritis patients in Switzerland: a qualitative study. Pain Res Manag 19(2):61–68

    Article  Google Scholar 

  40. Caballero AE (2011) Understanding the Hispanic/Latino patient. Am J Med 124(10 Suppl):S10–S15. https://doi.org/10.1016/j.amjmed.2011.07.018

    Article  PubMed  Google Scholar 

  41. Polonsky WH, Henry RR (2016) Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence 10:1299–1307. https://doi.org/10.2147/PPA.S106821

    Article  PubMed  PubMed Central  Google Scholar 

  42. Cherubini P, Rumiati R, Bigoni M, Tursi V, Livi U (2003) Long-term decrease in subjective perceived efficacy of immunosuppressive treatment after heart transplantation. J Heart Lung Transplant 22(12):1376–1380

    Article  Google Scholar 

  43. Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, O’Malley KJ, Janssen NM, Marcus DM, Tagore J, Suarez-Almazor ME (2005) Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 32(5):913–919

    PubMed  Google Scholar 

  44. da Mota LM, Brenol CV, Palominos P, Pinheiro Gda R (2015) Rheumatoid arthritis in Latin America: the importance of an early diagnosis. Clin Rheumatol 34(Suppl 1):S29–S44. https://doi.org/10.1007/s10067-015-3015-x

    Article  PubMed  Google Scholar 

  45. Rocha FA (2017) Latin-American challenges and opportunities in rheumatology. Arthritis Res Ther 19(1):29–23. https://doi.org/10.1186/s13075-017-1247-7

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank all patients and physicians who took part in the survey. Derek Ho, PhD, and Elizabeth A. Holdsworth provided medical writing support in the development of this manuscript. Olivia Massey provided statistical expertise.

Author information

Authors and Affiliations

  1. Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Enrique Roberto Soriano

  2. Janssen Cilag Farmacéutica S.A, Buenos Aires, Argentina

    Federico Zazzetti

  3. Universidade Federal de Santa Catarina, Hospital Universitário, Divisão de Reumatologia, Florianópolis, SC, Brazil

    Ivanio Alves Pereira

  4. School of Medicine, Buenos Aires University, Buenos Aires, Argentina

    José Maldonado Cocco

  5. Federal University of Paraná, Curitiba, PR, Brazil

    Valderilio Feijó Azevedo

  6. Centro Médico Royal Center Paitilla, Internal Medicine and Rheumatology, Panamá, Panama

    Generoso Guerra

  7. Rheumatology Section, University Hospital Fundación Santa Fe de Bogotá, Bogotá, Colombia

    Wilson Bautista-Molano

  8. Servicio de Reumatologia del Hospital General de México, Ciudad de México, Mexico

    Julio César Casasola

  9. Universidad Autónoma de Nuevo León, Rheumatology Service, Monterrey, Mexico

    David Vega Morales

  10. ART Medica - Hospital Universitario Mayor MEDERI, Internal Medicine and Rheumatology, Bogotá, Colombia

    Diana Rocío Gil

  11. Adelphi Real World, Bollington, UK

    Steve Lobosco

  12. Janssen Cilag Farmacéutica, São Paulo, Brazil

    Fabio Lawson

Authors
  1. Enrique Roberto Soriano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Federico Zazzetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ivanio Alves Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. José Maldonado Cocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Valderilio Feijó Azevedo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Generoso Guerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wilson Bautista-Molano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Julio César Casasola
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David Vega Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Diana Rocío Gil
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Steve Lobosco
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Fabio Lawson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steve Lobosco.

Ethics declarations

Conflict of interest

All authors have access to the primary data and agree the journal can review data if requested. FZ and FL are employees of Janssen, who sponsored this research. SL is an employee of Adelphi Real World, who received funding from Janssen for this research. Other authors do not have a financial relationship with Janssen. A further and complete list of financial and non-financial disclosures for all authors follows: ES participated as Advisory board member, speaker or received grant support from AbbVie, Amgen, Bristol-Myers Squibb, GSK, Genzyme, Janssen, Lilly, Novartis, Pfizer, Roche, Sandoz, Sanofi, and UCB; IAP participated as Advisory board member from Novartis, Pfizer, and Janssen, and speaker to Janssen, Abbvie, Lilly, Roche, Pfizer, and Novartis; JMC received consulting fees and/or participated in Speakers’ Bureau for Pfizer, Merck Sharp and Dohme, Sanofi–Aventis, Genzyme, Novartis, Bristol-Myers Squibb, Roche, Boehringer-Ingelheim, Schering–Plough, Abbott, UCB, Eli Lilly, and Gilead; VFA received research funds from Abbvie, GSK, Janssen, Pfizer, BMS, Lilly, Boehringer-Ingelheim, Genentech, and UCB, participated as Advisory board member from Sandoz, Novartis, Lilly, Pfizer, Boehringer-Ingelheim, and Janssen, and speaker to Boehringer-Ingelheim, Janssen, Abbvie, Lilly, Celltrion, Pfizer, and Novartis; GG has no further conflicts of interest to disclose; WBM participated as speaker from Bristol-Myers Squibb, Janssen, Lilly, Novartis, and Pfizer; JCC participated as speaker from Abbvie, UCB, Jannsen, Pfzier, Novartis, Roche, and Celgene, and as Advisory board member from UCB, Jannsen, and Novartis; DVM participated as Advisory board member, speaker, or received grant support from Abbvie, Roche, UCB, and Pfizer; DRG participated as Advisory board member from Janssen and Lilly, and speaker from AbbVie, Amgen, Bristol-Myers Squibb, Janssen, Pfizer, and Roche; SL is an employee of Adelphi Real World and has no further conflicts of interest to disclose; FZ and FL are employees of Janssen and have no further conflicts of interest to disclose.

Ethical standards

All participating patients provided informed consent for use of their anonymized and aggregated data for research and publication in scientific journals. Data collection was performed such that patients and physicians could not be identified directly, and all data were aggregated and de-identified before receipt. Data collection was performed in accordance with the European Pharmaceutical Marketing Research Association guidelines; ethics committee approval was thus not required. Each survey was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996 [34] and Health Information Technology for Economic and Clinical Health Act legislation [35].

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(PDF 179 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soriano, E.R., Zazzetti, F., Alves Pereira, I. et al. Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America. Clin Rheumatol 39, 1859–1869 (2020). https://doi.org/10.1007/s10067-019-04870-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04870-1

Keywords

Search

Navigation